Ostatní
Návod 
Neogen Corporation
NEOG
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.4B
Obrat
1B
Zisk
-1B
Aktiva
3B
Dluh
1B
ROE
0%
ROA
0%
PE
-4
PS
3
Cena 1R
4-12
⌀ Cena
5.93
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
08-04-2026
Poslední dividenda
Profil
Neogen Corporation společně se svými dceřinými společnostmi vyvíjí, vyrábí a prodává různé produkty pro bezpečnost potravin a zvířat po celém světě. Působí ve dvou segmentech, v oblasti bezpečnosti potravin a bezpečnosti zvířat. Segment bezpečnosti potravin nabízí diagnostické testovací sady a související produkty k detekci nebezpečných a nezamýšlených látek v potravinách a krmivech, včetně patogenů přenášených potravinami, organismů znehodnocujících organismy, přírodních toxinů, potravinových alergenů, genetických modifikací, vedlejších produktů z přežvýkavců, speciací masa, reziduí léčiv, reziduí pesticidů a obecných obav o hygienu; a AccuPoint Advanced rapid sanitation test ke zjištění přítomnosti adenosin trifosfátu, chemické látky nacházející se v živých buňkách. Tento segment nabízí své produkty především výrobcům a zpracovatelům potravin a krmiv, výrobcům a zpracovatelům obilí, výrobcům sušenek, krekrů, cukrovinek, zmrzliny a dalších zpracovaných potravin, zpracovatelům masa a drůbeže, zpracovatelům mořských plodů, výrobcům ovoce a zeleniny a mlékárnám, laboratořím a výrobcům farmaceutických, kosmetických a veterinárních vakcín. Segment bezpečnosti zvířat poskytuje veterinární nástroje, léčiva, vakcíny, témata, paraziticidy, diagnostické produkty, rodenticidy, čisticí prostředky, dezinfekční prostředky, insekticidy a služby testování genomiky pro trh bezpečnosti zvířat. Tento segment nabízí výzkumníkům různé produkty pro detekci biologicky aktivních látek. Jeho imunoanalytické testovací sady pro detekci léčiv se používají pro detekci zneužívaných a léčebných léků u hospodářských a závodních zvířat, detekci zbytků léčiv v mase a masných výrobcích a pro forenzní toxikologické aplikace screeningu léčiv. Kromě toho se produkty tohoto segmentu používají k udržení hygienických podmínek a omezení potenciálního nebezpečí bakterií, hub a virů. Neogen Corporation byla založena v roce 1981 a sídlí v Lansingu v Michiganu.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
2917
Založení
1989-08-23
Podobné společnosti
$ 1.33
- $ 0.01
$ 30.07
+ $ 0.70
$ 11.02
+ $ 0.10
$ 1.27
+ $ 0.03
$ 26.30
+ $ 0.37
$ 43.99
+ $ 0.02
$ 9.89
+ $ 0.37
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 880.3 | 894.7 | 924.2 | 822.4 | 527.2 | 468.5 | 418.2 | 414.2 | 402.3 | 361.6 | 321.3 | 283.1 | 247.4 | 207.5 | 184.0 | 172.7 | 140.5 | |
| Cost of Revenues | 545.4 | 473.3 | 461.6 | 416.5 | 284.1 | 253.4 | 221.9 | 222.3 | 212.0 | 189.6 | 168.2 | 143.4 | 124.8 | 98.0 | 91.6 | 84.9 | 67.5 | |
| Gross Profit | 335.0 | 421.4 | 462.6 | 406.0 | 243.0 | 215.1 | 196.3 | 191.9 | 190.3 | 172.0 | 153.1 | 139.7 | 122.6 | 109.5 | 92.4 | 87.8 | 73.0 |
| Revenue | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 224.7 | 209.2 | 225.5 | 221.0 | 231.3 | 217.0 | 236.8 | 228.8 | 229.6 | 229.0 | |
| Cost of Revenues | 118.0 | 137.2 | 156.1 | 134.0 | 141.5 | 130.5 | 123.3 | 113.2 | 112.9 | 112.2 | |
| Gross Profit | 106.7 | 72.0 | 69.3 | 87.0 | 89.7 | 86.4 | 113.5 | 115.6 | 116.8 | 116.8 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 26.0 | 17.0 | 16.2 | 14.8 | 12.8 | 10.9 | 10.4 | 9.9 | 9.6 | 8.3 | 7.8 | 6.6 | 6.8 | 6.3 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 342.4 | 167.3 | 124.6 | 114.0 | 111.0 | 109.2 | 96.6 | 86.8 | 77.0 | 70.9 | 61.0 | 52.1 | 45.1 | 39.8 | |
| Depreciation & Amortization | 117.6 | 125.7 | 121.2 | 88.4 | 23.7 | 21.0 | 18.4 | 17.6 | 17.1 | 14.7 | 12.5 | 10.6 | 9.2 | 7.4 | 6.2 | 5.3 | 4.4 | |
| Total Operating Expenses | 352.2 | 412.0 | 385.2 | 368.4 | 184.4 | 140.9 | 128.8 | 123.8 | 120.1 | 107.0 | 96.7 | 86.6 | 79.2 | 68.8 | 58.7 | 52.0 | 46.1 | |
| Operating Income | -17.2 | 9.4 | 77.4 | 37.5 | 34.9 | 53.1 | 49.1 | 50.5 | 70.2 | 64.9 | 56.4 | 53.1 | 43.4 | 40.7 | 33.7 | 35.8 | 26.9 |
| Operating Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 28.9 | 29.1 | 30.3 | 29.4 | 30.0 | 29.8 | 28.9 | 29.7 | 29.5 | 28.7 | ||
| Total Operating Expenses | 112.1 | 88.0 | 77.2 | 75.0 | 72.7 | 77.8 | 95.9 | 103.9 | 95.9 | 97.6 | ||
| Operating Income | -5.4 | -16.0 | -7.9 | 12.0 | 17.1 | 8.7 | 17.6 | 11.7 | 20.9 | 19.1 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.9 | 3.1 | 6.4 | 3.2 | 1.3 | 1.6 | 6.0 | 4.7 | 2.0 | 0.8 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Interest Expense | 66.2 | 71.6 | 73.4 | 56.0 | 1.3 | 0.0 | 0.0 | -22.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -600.2 | -1,142.5 | -91.7 | -59.6 | 25.3 | 22.1 | 23.2 | 22.5 | 3.3 | 1.7 | -0.9 | -1.0 | -0.4 | 0.4 | 0.2 | -0.7 | 0.4 | |
| IBT | -617.5 | -1,133.1 | -14.3 | -22.0 | 60.2 | 75.3 | 72.3 | 73.0 | 73.5 | 66.7 | 55.5 | 52.1 | 43.0 | 41.1 | 34.0 | 35.2 | 27.3 | |
| Income Tax Expense | -14.7 | -41.1 | -4.9 | 0.8 | 11.9 | 14.4 | 12.8 | 12.8 | 10.3 | 22.7 | 19.0 | 18.5 | 15.0 | 14.1 | 11.5 | 12.4 | 9.8 | |
| Net Income | -602.7 | -1,092.0 | -9.4 | -22.9 | 48.3 | 60.9 | 59.5 | 60.2 | 63.1 | 43.8 | 36.6 | 33.5 | 28.2 | 27.2 | 22.5 | 22.8 | 17.5 |
| Net Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.6 | 0.9 | 0.6 | 0.7 | 0.8 | 1.0 | 1.1 | 1.6 | 1.9 | 1.8 | ||
| Interest Expense | 14.8 | 16.4 | 17.1 | 17.7 | 18.1 | 18.6 | 18.6 | 18.3 | 18.0 | 18.5 | ||
| Other Expense | -15.0 | 59.8 | -623.3 | -21.7 | -493.6 | -24.3 | -24.0 | -17.5 | -24.7 | -17.5 | ||
| IBT | -20.4 | 43.8 | -631.2 | -9.7 | -476.6 | -15.6 | -6.4 | -5.8 | -3.7 | 1.7 | ||
| Income Tax Expense | -4.4 | 7.5 | -19.0 | 1.2 | -20.3 | -3.0 | -1.0 | -3.8 | -0.3 | 0.2 | ||
| Net Income | -15.9 | 36.3 | -612.2 | -11.0 | -456.3 | -12.6 | -5.4 | -2.0 | -3.5 | 1.5 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.12 | $0.45 | $0.57 | $0.56 | $0.58 | $0.61 | $0.43 | $0.36 | $0.34 | $0.29 | $0.28 | $0.24 | $0.25 | $0.19 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.12 | $0.45 | $0.57 | $0.56 | $0.58 | $0.61 | $0.43 | $0.36 | $0.34 | $0.28 | $0.28 | $0.24 | $0.24 | $0.19 | |
| Shares Outstanding | 217.4 | 216.9 | 216.5 | 188.9 | 107.7 | 107.5 | 105.7 | 104.4 | 103.5 | 101.9 | 100.2 | 99.0 | 98.0 | 96.2 | 94.5 | 92.0 | 89.5 | |
| Diluted Shares Outstanding | 217.4 | 216.9 | 216.5 | 188.9 | 108.0 | 107.5 | 105.7 | 104.7 | 104.4 | 102.3 | 101.0 | 99.9 | 99.4 | 97.3 | 96.1 | 95.2 | 92.4 |
| Per Share Data | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 217.4 | 217.0 | 217.0 | 217.0 | 216.8 | 216.7 | 216.6 | 216.6 | 216.4 | 216.3 | ||
| Diluted Shares Outstanding | 217.4 | 217.0 | 217.0 | 217.0 | 216.8 | 216.7 | 216.6 | 216.6 | 216.4 | 216.8 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 170.6 | 129.0 | 170.6 | 163.2 | 381.1 | 381.1 | 343.7 | 267.5 | 210.8 | 143.6 | 107.8 | 114.2 | 76.5 | 85.4 | 68.6 | 35.8 | 22.8 | |
| Short Term Investments | 0.3 | 0.0 | 0.3 | 82.3 | 336.6 | 305.5 | 277.4 | 225.8 | 127.7 | 66.1 | 52.5 | 48.1 | 35.8 | 35.3 | 19.6 | 20.2 | 0.0 | |
| Total Cash & ST Investments | 170.9 | 129.0 | 170.9 | 245.6 | 381.1 | 381.1 | 343.7 | 267.5 | 210.8 | 143.6 | 107.8 | 114.2 | 76.5 | 85.4 | 68.6 | 56.1 | 22.8 | |
| Accounts Receivable | 173.0 | 153.4 | 173.0 | 153.3 | 99.7 | 91.8 | 84.7 | 82.6 | 79.1 | 68.6 | 67.7 | 59.2 | 51.9 | 38.7 | 35.7 | 28.6 | 27.4 | |
| Inventory | 189.3 | 190.9 | 189.3 | 133.8 | 122.3 | 100.7 | 95.1 | 86.0 | 76.0 | 73.1 | 64.4 | 51.6 | 51.2 | 38.3 | 35.0 | 32.0 | 31.3 | |
| Other Current Assets | 56.0 | 103.7 | 56.0 | 53.3 | 23.8 | 17.8 | 14.0 | 13.4 | 9.9 | 7.6 | 10.2 | 6.2 | 9.2 | 6.0 | 4.7 | 5.8 | 4.5 | |
| Total Current Assets | 589.2 | 576.9 | 589.2 | 585.9 | 626.8 | 591.5 | 537.4 | 449.5 | 375.8 | 293.0 | 250.0 | 231.2 | 188.7 | 168.4 | 143.9 | 122.5 | 86.0 |
| Current Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 138.9 | 129.0 | 127.7 | 140.2 | 120.5 | 170.6 | 161.4 | 205.8 | 178.8 | 163.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 7.0 | 24.5 | 60.4 | 82.3 | |
| Total Cash & ST Investments | 138.9 | 129.0 | 127.7 | 140.2 | 120.5 | 170.9 | 168.4 | 230.3 | 239.3 | 245.6 | |
| Accounts Receivable | 138.5 | 153.4 | 160.1 | 164.1 | 167.6 | 173.0 | 173.6 | 150.5 | 137.7 | 153.3 | |
| Inventory | 193.4 | 190.9 | 205.4 | 198.3 | 198.6 | 189.3 | 182.4 | 160.5 | 140.7 | 133.8 | |
| Other Current Assets | 53.3 | 103.7 | 58.5 | 67.9 | 53.9 | 56.0 | 78.0 | 83.1 | 66.2 | 53.3 | |
| Total Current Assets | 524.1 | 576.9 | 551.7 | 570.4 | 540.7 | 589.2 | 602.5 | 624.4 | 583.8 | 585.9 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 291.9 | 356.3 | 291.9 | 198.7 | 110.6 | 100.5 | 78.7 | 74.8 | 73.1 | 61.7 | 54.7 | 44.5 | 41.9 | 34.3 | 29.9 | 22.3 | 19.2 | |
| Goodwill | 2,135.6 | 1,064.9 | 2,135.6 | 3,769.8 | 255.5 | 228.3 | 181.1 | 171.4 | 169.2 | 173.7 | 147.0 | 116.5 | 114.6 | 86.5 | 77.7 | 51.6 | 52.9 | |
| Intangible Assets | 1,511.7 | 1,410.5 | 1,511.7 | 1,605.1 | 107.5 | 92.3 | 66.6 | 67.7 | 69.6 | 68.9 | 58.5 | 46.4 | 46.4 | 28.3 | 24.7 | 17.2 | 17.2 | |
| Long-Term Investments | 0.2 | 0.0 | 0.2 | -34.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -5.7 | |
| Other Long-Term Assets | 20.2 | 35.2 | 20.2 | 15.2 | 0.0 | 0.0 | 0.0 | -15.6 | 0.0 | 0.0 | -1.8 | 0.0 | -1.7 | -1.5 | -1.3 | 6.1 | 5.0 | |
| Total Long-Term Assets | 3,994.9 | 2,866.9 | 3,959.6 | 3,968.5 | 366.1 | 328.7 | 259.8 | 246.2 | 242.2 | 235.4 | 201.7 | 161.0 | 156.6 | 120.8 | 107.7 | 97.2 | 94.2 | |
| Total Assets | 4,584.2 | 3,443.8 | 4,548.8 | 4,554.4 | 992.9 | 920.2 | 797.2 | 695.7 | 618.0 | 528.4 | 451.7 | 392.2 | 345.3 | 289.3 | 251.6 | 219.7 | 180.2 |
| Long-Term Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 362.9 | 511.7 | 345.2 | 327.8 | 315.3 | 291.9 | 287.6 | 259.3 | 235.6 | 198.7 | |
| Goodwill | 1,065.9 | 1,064.9 | 1,671.7 | 1,672.5 | 2,137.5 | 2,135.6 | 2,136.3 | 2,138.0 | 2,137.6 | 3,769.8 | |
| Intangible Assets | 1,389.1 | 1,410.5 | 1,439.2 | 1,463.2 | 1,489.8 | 1,511.7 | 1,539.7 | 1,564.7 | 1,588.1 | 1,605.1 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | -34.6 | |
| Other Long-Term Assets | 36.2 | -120.2 | 28.5 | 20.2 | 20.0 | 20.2 | -337.5 | -339.0 | -338.7 | 15.2 | |
| Total Long-Term Assets | 2,854.1 | 2,866.9 | 3,484.6 | 3,483.6 | 3,962.5 | 3,994.9 | 3,980.0 | 3,978.0 | 3,977.3 | 3,968.5 | |
| Total Assets | 3,378.2 | 3,443.8 | 4,036.3 | 4,054.1 | 4,503.2 | 4,584.2 | 4,582.5 | 4,602.4 | 4,561.1 | 4,554.4 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 83.1 | 79.6 | 83.1 | 76.7 | 34.6 | 23.9 | 25.7 | 19.1 | 20.8 | 16.2 | 15.8 | 13.7 | 13.4 | 9.2 | 10.8 | 8.5 | 7.2 | |
| Short-Term Debt | 7.5 | 27.4 | 7.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 59.1 | 55.9 | 48.6 | 57.2 | 37.8 | 29.7 | 22.8 | 19.2 | 17.9 | 19.8 | 12.8 | 11.8 | 11.6 | 8.5 | 9.2 | 9.3 | 9.8 | |
| Current Liabilities | 154.3 | 174.0 | 154.3 | 145.5 | 77.8 | 53.6 | 48.5 | 38.3 | 38.7 | 36.0 | 28.6 | 25.5 | 25.0 | 17.7 | 20.0 | 17.8 | 17.0 |
| Current Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 76.6 | 79.6 | 72.2 | 79.6 | 61.5 | 83.1 | 89.7 | 112.2 | 90.2 | 76.7 | |
| Short-Term Debt | 0.0 | 27.4 | 2.5 | 2.6 | 2.7 | 7.5 | 2.5 | 2.6 | 2.6 | 0.0 | |
| Other Current Liabilities | 54.3 | 55.9 | 47.8 | 52.2 | 41.8 | 48.6 | 48.5 | 47.0 | 36.1 | 57.2 | |
| Current Liabilities | 146.2 | 174.0 | 141.2 | 151.2 | 122.7 | 154.3 | 157.8 | 176.6 | 138.1 | 145.5 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 888.4 | 887.7 | 898.7 | 894.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 10.3 | 20.9 | 2.4 | 8.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 362.0 | 280.9 | 0.0 | 353.4 | 17.0 | 21.9 | 18.1 | 15.6 | 14.1 | 17.0 | 16.5 | 13.7 | 12.2 | 12.4 | 10.0 | 8.3 | 5.8 | |
| Total Liabilities | 1,440.0 | 1,372.6 | 1,404.7 | 1,420.2 | 105.6 | 79.8 | 72.0 | 57.8 | 57.8 | 56.7 | 47.6 | 41.2 | 39.0 | 31.0 | 32.5 | 30.7 | 27.2 |
| Long-Term Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 792.5 | 887.7 | 890.6 | 889.9 | 889.1 | 898.7 | 887.7 | 886.9 | 886.2 | 894.3 | |
| Capital Leases | 0.0 | 20.9 | 2.5 | 2.6 | 2.7 | 10.3 | 2.5 | 2.6 | 2.6 | 8.8 | |
| Def. Tax Liability | 277.3 | 280.9 | 301.1 | 302.4 | 317.6 | 362.0 | 353.9 | 355.0 | 354.8 | 353.4 | |
| Total Liabilities | 1,259.5 | 1,372.6 | 1,376.0 | 1,385.0 | 1,368.0 | 1,440.0 | 1,436.3 | 1,454.8 | 1,414.9 | 1,420.2 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 34.7 | 34.7 | 34.7 | 34.6 | 17.2 | 17.2 | 8.5 | 8.4 | 8.3 | 471.8 | 404.2 | 351.0 | 306.3 | 258.3 | 219.1 | 3.7 | 3.6 | |
| Retained Earnings | 555.6 | -536.4 | 555.6 | 565.0 | 587.9 | 539.6 | 478.7 | 419.2 | 359.1 | 295.9 | 252.1 | 215.6 | 182.0 | 153.9 | 126.7 | 104.1 | 81.2 | |
| Comprehensive Income | -30.0 | -28.9 | -30.0 | -33.3 | -27.8 | -11.4 | -19.7 | -11.6 | -9.7 | -7.2 | -3.9 | -2.4 | 0.4 | -1.4 | -1.2 | -0.4 | -1.7 | |
| Total Common Equity | 3,144.1 | 2,071.3 | 3,144.1 | 3,134.2 | 887.4 | 840.4 | 725.2 | 637.9 | 560.2 | 471.8 | 404.2 | 351.0 | 306.3 | 258.3 | 219.1 | 188.6 | 153.1 |
| Total Common Equity | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 34.8 | 34.7 | 34.7 | 34.7 | 34.7 | 34.7 | 34.7 | 34.6 | 34.6 | 34.6 | |
| Retained Earnings | -500.1 | -536.4 | 75.8 | 86.7 | 543.0 | 555.6 | 561.0 | 563.1 | 566.5 | 565.0 | |
| Comprehensive Income | -23.5 | -28.9 | -47.7 | -44.7 | -31.4 | -30.0 | -29.5 | -25.1 | -26.5 | -33.3 | |
| Total Common Equity | 2,118.6 | 2,071.3 | 2,660.3 | 2,669.1 | 3,135.2 | 3,144.1 | 3,146.2 | 3,147.6 | 3,146.2 | 3,134.2 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 906.2 | 912.6 | 906.2 | 900.0 | 986.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 3,144.1 | 2,071.3 | 3,144.1 | 3,134.2 | 887.4 | 840.4 | 725.2 | 637.9 | 560.2 | 471.8 | 404.2 | 351.0 | 306.3 | 258.3 | 219.1 | 189.0 | 153.1 |
| Other | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,118.6 | 2,071.3 | 2,660.3 | 2,669.1 | 3,135.2 | 3,144.1 | 3,146.2 | 3,147.6 | 3,146.2 | 3,134.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -9.4 | -1,092.0 | -9.4 | -22.9 | 48.3 | 60.9 | 59.5 | 60.2 | 63.2 | 44.0 | 36.5 | 33.6 | 28.0 | 27.0 | 22.5 | 22.8 | 17.5 | |
| Depreciation & Amortization | 116.7 | 125.7 | 121.2 | 88.4 | 23.7 | 21.0 | 18.4 | 17.6 | 17.1 | 14.7 | 12.5 | 10.6 | 9.2 | 7.4 | 6.2 | 5.3 | 4.4 | |
| Stock-Based Compensation | 13.8 | 17.3 | 0.0 | 10.2 | 7.2 | 6.4 | 6.5 | 5.5 | 4.9 | 5.3 | 5.5 | 4.5 | 3.7 | 3.1 | 2.5 | 2.2 | 2.2 | |
| Change Working Capital | -72.7 | -5.9 | -72.7 | -22.8 | -6.4 | -6.6 | -0.1 | -20.7 | -13.1 | 0.6 | -18.2 | -2.9 | -13.9 | -8.1 | -8.4 | -0.8 | 4.9 | |
| Change In Accounts Receivable | -20.1 | 11.6 | -20.1 | -53.9 | -7.8 | -2.6 | -2.9 | -4.0 | -10.2 | 5.0 | -6.0 | -7.3 | -10.6 | -2.7 | -7.2 | -0.9 | -2.2 | |
| Change In Accounts Payable | 13.8 | -0.4 | 13.8 | 18.6 | 10.2 | -3.2 | 6.7 | -1.5 | 4.4 | -1.7 | 0.7 | 0.4 | 2.0 | -1.4 | 2.3 | 1.2 | 3.0 | |
| Change In Inventories | -55.9 | -16.1 | -55.9 | 10.0 | -21.1 | 2.5 | -10.0 | -10.4 | -2.6 | -7.0 | -9.4 | 0.3 | -3.5 | -2.1 | -3.1 | -0.4 | 0.1 | |
| Other Non-cash Items | 94.8 | 1,071.0 | 23.0 | 7.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.9 | -2.9 | -2.5 | -4.8 | -3.1 | -1.8 | -3.0 | -0.9 | |
| Cash from Operations | 35.2 | 0.0 | 0.0 | 41.0 | 68.0 | 81.1 | 85.9 | 63.8 | 69.1 | 60.3 | 35.3 | 43.8 | 21.7 | 26.6 | 22.3 | 28.8 | 28.0 |
| Cash Flow From Operating Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -15.9 | 36.3 | -612.2 | -11.0 | -456.3 | -12.6 | -5.4 | -2.0 | -3.5 | 1.5 | |
| Depreciation & Amortization | 28.9 | 29.1 | 36.5 | 29.4 | 30.0 | 29.8 | 28.9 | 29.7 | 29.5 | 28.7 | |
| Stock-Based Compensation | 4.3 | 5.0 | 4.3 | 4.2 | 4.8 | 4.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change Working Capital | 6.8 | 21.5 | 14.8 | 3.1 | 6.8 | -30.6 | 15.8 | -61.2 | -15.6 | -11.7 | |
| Change In Accounts Receivable | -6.3 | 17.6 | 2.5 | 3.8 | 0.5 | 4.8 | -4.0 | -19.8 | -12.6 | 16.2 | |
| Change In Accounts Payable | -9.3 | 14.2 | -6.4 | 3.8 | 18.0 | -15.9 | -7.6 | -13.6 | 30.0 | 5.0 | |
| Change In Inventories | 18.7 | -2.0 | 9.0 | -7.7 | -7.5 | -9.9 | -7.3 | -22.7 | -19.6 | -6.3 | |
| Other Non-cash Items | 0.7 | -75.1 | 597.8 | 2.9 | 469.7 | 0.7 | 14.9 | 4.4 | 4.7 | 3.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -111.4 | -104.6 | -111.4 | -65.8 | -24.4 | -26.7 | -24.1 | -14.7 | -20.9 | -14.6 | -14.2 | -9.6 | -11.5 | -8.9 | -12.4 | -7.8 | -5.4 | |
| Acquisitions | 0.1 | 5.1 | 0.1 | 11.7 | -38.7 | -50.8 | -13.2 | -6.4 | -0.5 | -34.0 | -42.5 | -6.6 | -39.3 | -13.3 | -4.0 | 7.8 | -20.3 | |
| Investments | 0.0 | 0.0 | 0.0 | -12.5 | -415.9 | -792.7 | -458.3 | -437.3 | -361.4 | -162.8 | -151.6 | -105.9 | -91.7 | -82.8 | -71.6 | -60.3 | 0.0 | |
| Sales of Investment | 82.0 | 0.3 | 82.0 | 266.8 | 381.8 | 764.6 | 406.7 | 339.2 | 299.8 | 149.2 | 147.2 | 93.7 | 91.2 | 67.0 | 72.3 | 40.1 | 0.0 | |
| Other Investing Activities | 6.8 | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.8 | 0.0 | |
| Cash from Investing | -29.3 | 0.0 | 0.0 | 201.0 | -97.2 | -105.6 | -88.8 | -119.1 | -83.1 | -62.1 | -61.1 | -28.5 | -51.3 | -38.0 | -15.8 | -28.0 | -25.7 |
| Cash Flow From Investing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -11.7 | -24.0 | -16.1 | -32.9 | -17.2 | -38.4 | -24.3 | -32.1 | -24.4 | -30.6 | |
| Acquisitions | 0.0 | 121.7 | 0.2 | 0.4 | 0.0 | 4.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 6.7 | 17.5 | 35.9 | 21.9 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | -100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 20.8 | 6.4 | 6.2 | 13.3 | 986.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 2.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.5 | 0.0 | 0.0 | -19.3 | 6.8 | 33.5 | 29.4 | 17.0 | 22.8 | 25.1 | 15.3 | 11.0 | 19.6 | 12.5 | 6.9 | 12.0 | 6.7 | |
| Cash from Financing | 2.0 | 0.0 | 0.0 | -118.1 | 6.8 | 33.5 | 29.4 | 13.9 | 22.8 | 25.1 | 15.3 | 11.0 | 19.6 | 12.5 | 6.9 | 12.0 | 6.7 |
| Cash Flow From Financing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 792.5 | -120.1 | 19.5 | 0.7 | 0.7 | -14.5 | 16.1 | 0.7 | 0.7 | 3.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 7.4 | -41.6 | 7.4 | 118.8 | -31.1 | 9.3 | 24.6 | -41.4 | 5.5 | 22.3 | -10.8 | 25.4 | -9.4 | 1.0 | 13.2 | 13.0 | 9.0 | |
| Closing Cash Balance | 170.6 | 129.0 | 170.6 | 163.2 | 44.5 | 75.6 | 66.3 | 41.7 | 83.1 | 77.6 | 55.3 | 66.1 | 40.7 | 50.0 | 49.0 | 35.8 | 22.8 |
| Cash position | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 6.5 | 9.9 | 1.3 | -12.5 | 19.8 | -50.1 | 9.2 | -44.3 | 26.9 | 15.6 | |
| Closing Cash Balance | 145.3 | 138.9 | 129.0 | 127.7 | 140.2 | 120.5 | 170.6 | 161.4 | 205.8 | 178.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -76.3 | -46.4 | -76.7 | -24.7 | 43.6 | 54.4 | 61.8 | 49.2 | 48.2 | 45.7 | 21.1 | 34.2 | 10.1 | 17.7 | 9.9 | 21.0 | 22.6 | |
| Real Free Cash Flow | -90.0 | -63.6 | -76.7 | -34.9 | 36.5 | 47.9 | 55.4 | 43.6 | 43.3 | 40.4 | 15.6 | 29.7 | 6.4 | 14.6 | 7.4 | 18.8 | 20.3 |
| Free Cash Flow | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 43.4 | -13.1 | 0.4 | -13.5 | 23.1 | -56.3 | 2.4 | -62.4 | -9.1 | -7.6 | |
| Real Free Cash Flow | 39.1 | -18.1 | -3.9 | -17.7 | 18.3 | -60.3 | 2.4 | -62.4 | -9.1 | -7.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -3.9 | 40.3 | 63 |
| P/S | 2.7 | 6.4 | 57.8 |
| P/B | 1.1 | 4.4 | 29.8 |
| P/FCF | -3952.2 | 133 | 549.4 |
| Market cap | $1.4 | $25.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 5.1 % | 0 % |
| Debt to Income | -131.5 % | 503.5 % | 0 % |
| Debt to Free cash flow | -133647.6 % | 6.5 % | 0 % |
| Interest expense percentage | -383.8 % | 39.9 % | 2.9 % |
| Current ratio | 3.6 | 7.8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -28.4 % | 5.3 % | 0 % |
| ROA | -17.8 % | 5.3 % | 0 % |
| CapEx to Revenue | 9.6 % | 5.5 % | 0 % |
| RaD to Revenue | 0 % | 3.2 % | 0 % |
| ROEM | 296,005.0 | 1652568.7 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 38 % | 48.5 % | 47.8 % |
| Operating margin | -2 % | 11.2 % | 28 % |
| Net margin | -68.5 % | 3.7 % | 19.8 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 217.4 mil | 123.8 mil |
| Employee count | 3.0 tis | 1.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
